New Hope, Pa.-based Orchestra Biomed Inc. scooped up $34 million in a series B-1 preferred stock financing led by Perceive Advisors, RTW Investments and Soleus Capital. The funds will be used to advance development of the company's Backbeat cardiac neuromodulation therapy (CNT) system, to support commitments to Orchestra's strategic global partnership with Tokyo-based Terumo Corp. for the development and marketing of the Virtue sirolimus-eluting balloon (SEB) and to grow the company's product pipeline and pursue future collaborations. Terumo and existing investors from Sternaegis Ventures also participated in the round. Read More
HONG KONG – Dia Imaging Analysis Ltd., of Be'er Sheva, Israel, has teamed up with Konica Minolta Healthcare Americas Inc. to explore the analytic potential of Dia's Lvivo Toolbox for cardiac analysis combined with Konica Minolta's Exa cardio PACS platform. Read More
